Shanghai MicuRx Pharmaceutical Co., Ltd.SSE: 688373

(688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Signing of Authorization and License Agreement with ClearideBio

· Issued by Shanghai MicuRx Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688373 · · 6 pages · Chinese

Summary by 6ix AI

The financial terms include an upfront payment and milestone payments contingent on project developments, with potential revenue sharing from future commercialization efforts. The company retains core intellectual property rights and emphasizes that the agreement does not constitute a major asset restructuring or related party transaction.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688373shanghai-micurx-pharmaceutical-co-ltdannouncement-on-signing-of-authorization-and-license-agreement-with-clearidebio

Release

Announcement on Signing of Authorization and License Agreement with ClearideBio

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shanghai MicuRx Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Shanghai MicuRx Pharmaceutical

All Shanghai MicuRx Pharmaceutical news releases